MINERVA NEUROSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.4 USD | +1.70% |
|
-5.14% | -60.98% |
| 27/02 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
| 27/02 | Top Midday Decliners | MT |
Chart calendar Minerva Neurosciences, Inc.
972dc1672f4aadcefff9b34.VjAQoeHNuMG_-4f1tJ7gECMr3mzPCc6NNZW9aMa6HX4.YXp_8JCvzaPdi_2F8O6jd3JCmBaYbb3bfcP_H_KMai17WSjFhY71nvqI1g~1b67173ced611b1889a87c03da42d32a
Upcoming events on Minerva Neurosciences, Inc.
Past events on Minerva Neurosciences, Inc.
| 22/02/2024 05:30 pm | Q4 2023 Earnings Release |
| 07/11/2023 06:00 pm | Q3 2023 Earnings Release |
| 27/09/2023 06:30 pm | Annual General Meeting |
| 01/08/2023 05:00 pm | Q2 2023 Earnings Release |
| 15/05/2023 06:00 pm | Q1 2023 Earnings Call |
| 15/05/2023 05:00 pm | Q1 2023 Earnings Release |
| 08/03/2023 07:00 pm | Q4 2022 Earnings Call |
| 08/03/2023 06:00 pm | Q4 2022 Earnings Release |
| 09/11/2022 07:00 pm | Q3 2022 Earnings Call |
| 09/11/2022 06:30 pm | Q3 2022 Earnings Release |
| 09/08/2022 05:30 pm | Interim 2022 Earnings Release |
| 10/06/2022 05:30 pm | Annual General Meeting |
| 04/05/2022 06:00 pm | Q1 2022 Earnings Release |
| 13/04/2022 08:30 pm | Roluperidone Update Call |
| 01/03/2022 06:00 pm | FY 2021 Earnings Release |
| 05/01/2022 | LifeSci Partners Corporate Access Event |
| 08/11/2021 07:00 pm | Q3 2021 Earnings Call |
| 08/11/2021 06:00 pm | Q3 2021 Earnings Release |
| 02/08/2021 06:00 pm | Interim 2021 Earnings Call |
| 02/08/2021 05:00 pm | Interim 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 41,2 41,2 -0.04% | 0,00 0,25 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -75,9 -59,9 -26.76% | 1,85 1,29 43.16% | -45,4 -31,7 -43.16% | -25,2 -25,7 1.64% | -23,1 -21,0 -10.09% | -25,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -74,4 -58,3 -27.66% | 1,94 1,36 42.88% | -51,7 -36,7 -40.95% | -32,1 -31,6 -1.56% | -30,0 -27,7 -8.44% | -32,4 |
|
Net income Million USD | Released Forecast Spread | -72,2 -57,9 -24.65% | 1,94 1,35 44.02% | -49,9 -36,6 -36.49% | -32,1 -31,6 -1.56% | -30,0 -27,7 -8.44% | -32,4 |
|
EPS USD | Released Forecast Spread | -14,8 -11,7 -26.02% | 0,40 0,27 47.06% | -9,36 -6,82 -37.24% | -6,01 -4,47 -34.55% | -4,61 -4,26 -8.22% | -3,57 |
| Announcement Date | 09/03/20 | 08/03/21 | 01/03/22 | 08/03/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,25 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | ||
|
EBIT Million USD | Released Forecast Spread | -21,4 -7,70 -177.61% | -7,99 -8,74 8.61% | -6,97 -8,49 17.95% | -5,21 -7,89 34.03% | -5,07 -5,49 7.65% | -5,35 -7,43 28% | -4,52 -5,58 19.05% | -6,08 -4,68 -29.98% | -7,17 -5,05 -41.94% | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,1 -8,09 -185.76% | -9,76 -9,11 -7.23% | -8,72 -9,16 4.8% | -6,90 -7,56 8.7% | -6,73 -6,23 -7.88% | -6,97 -8,72 20.07% | -6,19 -6,70 7.61% | -7,82 -5,79 -34.99% | -9,02 -6,65 -35.67% | ||||
|
Net income Million USD | Released Forecast Spread | -21,3 -8,09 -163.46% | -9,76 -8,80 -10.91% | -8,72 -9,16 4.8% | -6,90 -7,56 8.7% | -6,73 -6,23 -7.88% | -6,97 -8,72 20.07% | -6,19 -6,70 7.61% | -7,82 -5,79 -34.99% | -9,02 -6,65 -35.67% | ||||
|
EPS USD | Released Forecast Spread | -4,00 -1,50 -166.67% | -1,84 -1,48 -24.32% | -1,63 -1,52 -7.24% | -1,29 -1,32 2.09% | -1,26 -0,92 -36.96% | -1,31 -1,63 19.63% | -1,12 -0,44 -154.55% | -1,03 -0,77 -33.77% | -1,13 -1,20 5.83% | -0,77 | -0,81 | -0,86 | |
| Announcement Date | 01/03/22 | 04/05/22 | 09/08/22 | 09/11/22 | 08/03/23 | 15/05/23 | 01/08/23 | 07/11/23 | 22/02/24 | 01/05/24 | - | - | - |
| Today 03:30 pm | AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| Today 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 06/05/2024 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Minerva Neurosciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NERV Stock
- Calendar Minerva Neurosciences, Inc.
